Current Press Release

ClearLight Biotechnologies Signs an Exclusive License Agreement to Develop and Commercialize the CRYSTAL Technology, Invented at the University of Zurich and the University Hospital Zurich

Posted on Sep 10, 2019

SUNNYVALE, CA September 10, 2019 (PR NEWSWIRE)

ClearLight Biotechnologies, LLC announced today the execution of an exclusive world-wide license agreement to develop and commercialize the 3D tissue clearing technology, CRYSTAL, invented by Professor Adriano Aguzzi, M.D, Ph.D., and Daniel Kirschenbaum, M.D, Ph.D. at the University of Zurich and the University Hospital Zurich. The advantage of the CRYSTAL technology lies within a focused detergent-ion stream tailored to the sample to be optically cleared. Previous detergent electrophoretic methods for optical clearing, rely on an electric current irrespective of sample morphology. Thus, in these approaches the ion stream traverses the sample container along the path of least electrical resistance, which is simply the surrounding buffer solution. Modifying this with the CRYSTAL technology, to a focused electrophoretic approach enhances the clearing process multi-fold and allows the clarification of a 1 mm thick tissue biopsy in 30 minutes. CRYSTAL is easy to miniaturize and parallelize, and it has been successfully utilized in the academic setting to test multiple drugs in animal models of disease. Compared to clearing methods which are based on passively incubating samples in various solvents, active methods such as CLARITY and CRYSTAL allow for controlled expediting of the clearing process making it amenable to automation. Reproducible automation of a focused electrophoretic clearing process allows for rapid tissue clarification, making this technology highly amenable to future clinical applications.

“In surgical pathology, time is of the essence. By doing away with paraffin embedding and microtome cutting, the CRYSTAL technology allows for acquiring holographic ultra-high-resolution images of specimens more quickly than with conventional histology,” said Professor Aguzzi, Director of the Institute of Neuropathology.

Founder and Scientific Advisor, Karl Deisseroth M.D, Ph.D. said, “CRYSTAL is very powerful. The resulting combined technologies establish a new paradigm for fast and information-rich intact-tissue clinical histology, unmatched in the field.”

“We are eager to develop such an innovative technology that will advance the CLARITY, active tissue clearing field, said Laurie Goodman,” Ph.D. CEO of ClearLight.  “It adds a crucial piece to our growing intellectual property portfolio.  Furthermore, this capability along with the exclusivity to develop CLARITY for clinical applications will enable ClearLight to fully automate the process, to achieve competitive turnaround times associated with 2D thin section IHC methods.”

ClearLight aims to provide the next generation in normal and diseased tissue analysis by providing true 3D digital spatial analysis in 3D.

About ClearLight

Founded by Karl Deisseroth M.D, Ph.D., ClearLight is developing an automated instrumentation platform based on the CLARITY lipid-clearing technique developed by Dr. Deisseroth and colleagues at Stanford. This technique enables the transformation of tissue into a nanoporous, hydrogel-hybridized form that is crosslinked to a three-dimensional network of hydrophilic polymers. The process produces a fully assembled, intact tissue, which is permeable to macromolecules and optically transparent, thus allowing for robust three-dimensional imaging of subcellular components (DNA, RNA and protein) and analysis of heterogeneous cellular interactions within the microenvironment of a tissue. This technology, paired with proprietary 3D image analysis software, will enable more accurate analysis and assessment of normal and diseased tissue.

Please visit and follow us at:


Contact: Laurie Goodman, Ph.D., CEO
(800) 251-8905

Terms and Conditions

Please read these terms and conditions (“terms”, “terms and conditions”) carefully before using [website] website (the “service”) operated by [name] (“us”, ‘we”, “our”).

Conditions of Use

We will provide their services to you, which are subject to the conditions stated below in this document. Every time you visit this website, use its services or make a purchase, you accept the following conditions. This is why we urge you to read them carefully.

Privacy Policy

Before you continue using our website we advise you to read our privacy policy [link to privacy policy] regarding our user data collection. It will help you better understand our practices.


Content published on this website (digital downloads, images, texts, graphics, logos) is the property of [name] and/or its content creators and protected by international copyright laws. The entire compilation of the content found on this website is the exclusive property of [name], with copyright authorship for this compilation by [name].


The entire communication with us is electronic. Every time you send us an email or visit our website, you are going to be communicating with us. You hereby consent to receive communications from us. If you subscribe to the news on our website, you are going to receive regular emails from us. We will continue to communicate with you by posting news and notices on our website and by sending you emails. You also agree that all notices, disclosures, agreements and other communications we provide to you electronically meet the legal requirements that such communications be in writing.

Applicable Law

By visiting this website, you agree that the laws of the [your location], without regard to principles of conflict laws, will govern these terms and conditions, or any dispute of any sort that might come between [name] and you, or its business partners and associates.


Any dispute related in any way to your visit to this website or to products you purchase from us shall be arbitrated by state or federal court [your location] and you consent to exclusive jurisdiction and venue of such courts.

Comments, Reviews, and Emails

Visitors may post content as long as it is not obscene, illegal, defamatory, threatening, infringing of intellectual property rights, invasive of privacy or injurious in any other way to third parties. Content has to be free of software viruses, political campaign, and commercial solicitation.

We reserve all rights (but not the obligation) to remove and/or edit such content. When you post your content, you grant [name] non-exclusive, royalty-free and irrevocable right to use, reproduce, publish, modify such content throughout the world in any media.

License and Site Access

We grant you a limited license to access and make personal use of this website. You are not allowed to download or modify it. This may be done only with written consent from us.

User Account

If you are an owner of an account on this website, you are solely responsible for maintaining the confidentiality of your private user details (username and password). You are responsible for all activities that occur under your account or password.

We reserve all rights to terminate accounts, edit or remove content and cancel orders in their sole discretion.